Tokyo, Sept. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059204) titled 'A study to evaluate the safety of long-term consumption of blue rose extract powder' on Sept. 26.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - KINJIRUSHI Co., LTD.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety of long-term consumption of blue rose extract powder.
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Duration: 12 weeks
Test product...